Medical Science News

RSS

UCLA imaging system could help reveal 'miscommunications' in autism, schizophrenia

Some disorders of the brain are obvious - the massive death of brain cells after a stroke, the explosion in the growth of cells that marks a tumor. Other disorders, such as autism, schizophrenia and mental retardation show no physical signs of damage and are believed to be caused by problems in how brain cells communicate with one another.

13 Jan 2011

New research paper reveals key lessons about origins of 2009 H1N1 pandemic

How Swine Flu Overturned the Understanding of Pandemic Outbreaks. As H1N1 'Swine Flu' returns to the national headlines a new research paper reveals the key lessons about the origins of the 2009 pandemic. The paper, published today in BioEssays, reveals how the pandemic challenges the traditional understanding of 'antigenic shift', given that the virus emerged from an existing influenza subtype.

13 Jan 2011

Scientists quantify amount of energy lost during sleep deprivation

American scientists have quantified for the first time ever the amount of energy lost during a night of sleep deprivation according to new research published in The Journal of Physiology.

13 Jan 2011

Aβ, tau and Fyn protein interactions may lead to brain dysfunction and AD

Though the cause of Alzheimer's disease still is unknown, recent studies have implicated three proteins strongly in its onset. New research from the University of Alabama at Birmingham, the Gladstone Institutes and the Baylor College of Medicine indicates that interactions between those three proteins might lead to brain dysfunction and AD in a mouse model of the disease.

13 Jan 2011

Micromet, MedImmune initiate MT111 Phase 1 trial in patients with advanced gastrointestinal cancer

MedImmune, the global biologics unit of AstraZeneca PLC and Micromet, today announced the initiation of a Phase 1 trial of MEDI-565 in patients with advanced gastrointestinal cancers. MEDI-565 is a BiTE antibody designed to direct a patient's T cells, the body's most potent killer cells, against cancer cells that express carcinoembryonic antigen.

13 Jan 2011

Scientist develops FMR1 genetic blood test for predicting IVF outcomes

A researcher at Albert Einstein College of Medicine of Yeshiva University has helped to develop the first genetic blood test for predicting the chances that in vitro fertilization will lead to a successful pregnancy.

13 Jan 2011

FDA accepts to review Fibrocell Science's azficel-T drug

Fibrocell Science, a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that the U.S. Food & Drug Administration has accepted for review the Company's complete response submission for azficel-T, proposed brand name laViv, for the treatment of moderate to severe nasolabial folds and wrinkles.

12 Jan 2011

Study indicates disease's underlying causes in mice, finds compounds that normalize Alzheimer's brain

A Blanchette Rockefeller Neurosciences Institute study published today in the Journal of Neuroscience reveals underlying causes for the degeneration of synapses in Alzheimer's Disease and identifies promising pharmaceutical solutions for the devastating condition that affects more than 5 million people in the United States.

12 Jan 2011

Exiqon launches 2nd generation of miRCURY LNA microRNA Inhibitor libraries for genome-wide screening

Exiqon A/S, a leading supplier of high-value gene expression analysis products, today announced the launch of the 2nd generation of miRCURY LNA microRNA Inhibitor libraries for genome-wide screening of microRNA function in human and mouse. Several libraries have already been shipped to the first customers.

12 Jan 2011

Clostridium bacteria may offer a greener alternative to petrol

A diverse family of bacteria that can cause a potentially fatal illness in humans but could offer a greener alternative to petrol to power our cars will be the subject of a talk by a University of Nottingham academic at an international conference.

12 Jan 2011

Affymetrix enters distribution agreement with Fisher Scientific for GeneAtlas System

Affymetrix, Inc. today announced that it has signed a distribution agreement with Fisher Scientific, Inc., part of Thermo Fisher Scientific, to distribute the GeneAtlas™ System and its related consumables through the Fisher Scientific channel throughout the United States and Canada.

From Thermo Fisher Scientific Inc. 12 Jan 2011

Stem cell therapy enters anti-aging industry

While many scientists may state that stem cells are the key to longer and healthier lives, some are not waiting on the technology for that and are using it in the anti-aging industry to bring unmatched results in wrinkle removal. The ant-wrinkle and skin cream industry has been in a state of remission as far as advancements in the industry for decades.

12 Jan 2011

Lipoprotein receptor LRP1 also regulates food intake and energy balance in central nervous system: Study

A study by researchers at Mayo Clinic's campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a new molecular player responsible for the regulation of appetite and metabolism.

12 Jan 2011

Offensive protein generated by HPV handicaps defensive protein made by the human body

An international team of researchers is reporting that it has uncovered new information about human papillomavirus that one day may aid in the development of drugs to eliminate the cervical-cancer-causing infection.

12 Jan 2011

Doctors matter in treatment of breast cancer

A recent journal article presents evidence that suggests that the course of treatment that a doctor chooses to treat a breast cancer patient may play a larger role in expected outcomes than was previously believed. The Journal of the National Cancer Institute's article (online 01/03/2011; print 01/19/2011) Breast Cancer Outcome: Your Doctor Matters examines variations in outcomes from surgeon to surgeon.

12 Jan 2011

PLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine

Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper highlighting positive results from Inovio's multi-antigen Chikungunya virus (CHIKV) DNA vaccine in PLoS Neglected Tropical Diseases.

12 Jan 2011

Dream team to build mind-controlled prosthetic devices

University of Houston researchers are helping the Pentagon build reliable mind-controlled prosthetic devices that military and civilian amputees can use the rest of their lives.

12 Jan 2011

Study shows delivering cancer drug in hydrophobic nanoparticle is a safe and effective prostate cancer therapy

Researchers at MIT and Brigham and Women's Hospital have shown that they can deliver the cancer drug cisplatin much more effectively and safely in a form that has been encapsulated in a nanoparticle targeted to prostate tumor cells and is activated once it reaches its target.

12 Jan 2011

Rice, BCM discovery addresses key roadblock to growing replacement tissues, organs

Researchers from Rice University and Baylor College of Medicine (BCM) have broken one of the major roadblocks on the path to growing transplantable tissue in the lab: They've found a way to grow the blood vessels and capillaries needed to keep tissues alive.

12 Jan 2011

Study reveals underlying causes for degeneration of synapses in Alzheimer's Disease

A Blanchette Rockefeller Neurosciences Institute (BRNI) study published today in the Journal of Neuroscience reveals underlying causes for the degeneration of synapses in Alzheimer's Disease and identifies promising pharmaceutical solutions for the devastating condition that affects more than 5 million people in the United States.

12 Jan 2011

Medical Science News

UCLA imaging system could help reveal 'miscommunications' in autism, schizophrenia

New research paper reveals key lessons about origins of 2009 H1N1 pandemic

Scientists quantify amount of energy lost during sleep deprivation

Aβ, tau and Fyn protein interactions may lead to brain dysfunction and AD

Micromet, MedImmune initiate MT111 Phase 1 trial in patients with advanced gastrointestinal cancer

Scientist develops FMR1 genetic blood test for predicting IVF outcomes

FDA accepts to review Fibrocell Science's azficel-T drug

Study indicates disease's underlying causes in mice, finds compounds that normalize Alzheimer's brain

Exiqon launches 2nd generation of miRCURY LNA microRNA Inhibitor libraries for genome-wide screening

Clostridium bacteria may offer a greener alternative to petrol

Affymetrix enters distribution agreement with Fisher Scientific for GeneAtlas System

Stem cell therapy enters anti-aging industry

Lipoprotein receptor LRP1 also regulates food intake and energy balance in central nervous system: Study

Offensive protein generated by HPV handicaps defensive protein made by the human body

Doctors matter in treatment of breast cancer

PLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine

Dream team to build mind-controlled prosthetic devices

Study shows delivering cancer drug in hydrophobic nanoparticle is a safe and effective prostate cancer therapy

Rice, BCM discovery addresses key roadblock to growing replacement tissues, organs

Study reveals underlying causes for degeneration of synapses in Alzheimer's Disease

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News